BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6673015)

  • 1. [Blood viscosity in diabetes mellitus (evaluation on the basis of high shear rates)].
    Sarno A; Catania A; Capobianco D; Frazzetta F; Francavilla G; Caimi G
    Ric Clin Lab; 1983; 13 Suppl 3():367-70. PubMed ID: 6673015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood viscosity and erythrocyte filterability: their evaluation in diabetes mellitus.
    Caimi G
    Horm Metab Res; 1983 Oct; 15(10):467-70. PubMed ID: 6642407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of various hemorheologic parameters in diabetes mellitus].
    Cella A; Bianchi E; Reali GL; Piana A; Armani U
    Boll Soc Ital Biol Sper; 1990 Apr; 66(4):335-42. PubMed ID: 2390223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of red cell aggregation by low shear rate viscometry in whole blood with elevated plasma viscosity.
    Janzen J; Elliott TG; Carter CJ; Brooks DE
    Biorheology; 2000; 37(3):225-37. PubMed ID: 11026942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modification of hemorheological parameters in microvascular complications of diabetes].
    Bauduceau B; Renaudeau C; Mayaudon H; Hélie C; Ducorps M; Sonnet E; Yvert JP
    Diabete Metab; 1995 Jun; 21(3):188-93. PubMed ID: 7556810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell aggregation in diabetes mellitus.
    Le Devehat C; Vimeux M; Bondoux G; Khodabandehlou T
    Int Angiol; 1990; 9(1):11-5. PubMed ID: 2212794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythrocyte filterability in diabetes mellitus (a survey carried out by two methods)].
    Caimi G; Frazzetta F; Capobianco D; Catania A; Romano A; Sarno A
    Ric Clin Lab; 1983; 13 Suppl 3():363-6. PubMed ID: 6673014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcutaneous oxygen pressure and hemorheology in diabetes mellitus.
    Le Devehat C; Khodabandehlou T
    Int Angiol; 1990; 9(4):259-62. PubMed ID: 2099959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure and hematocrit in diabetes and the role of endothelial responses in the variability of blood viscosity.
    Salazar-Vazquez BY; Intaglietta M; Rodríguez-Morán M; Guerrero-Romero F
    Diabetes Care; 2006 Jul; 29(7):1523-8. PubMed ID: 16801573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood and plasma viscosity in diabetes: possible contribution to late organ complications?
    Schut NH; van Arkel EC; Hardeman MR; Bilo HJ; Michels RP; Vreeken J
    Diabetes Res; 1992 Jan; 19(1):31-5. PubMed ID: 1468184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved viscosity modeling in patients with type 2 diabetes mellitus by accounting for enhanced red blood cell aggregation tendency.
    Mutsaerts HJ; Out M; Goedhart PT; Ince C; Hardeman MR; Romijn JA; Rabelink TJ; Reiber JH; Box FM
    Clin Hemorheol Microcirc; 2010; 44(4):303-13. PubMed ID: 20571245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemorheological alterations in hypertensive patients].
    Foresto P; D'Arrigo M; Filippini F; Gallo R; Barberena L; Racca L; Valverde J; Rasia RJ
    Medicina (B Aires); 2005; 65(2):121-5. PubMed ID: 16075805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorheological disturbances as a marker of diabetic foot syndrome deterioration.
    Khodabandehlou T; Le Dévéhat C
    Clin Hemorheol Microcirc; 2004; 30(3-4):219-23. PubMed ID: 15258346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of cholesterol levels on hemorheological parameters in diabetic patients.
    Ercan M; Konukoğlu D; Erdem T; Onen S
    Clin Hemorheol Microcirc; 2002; 26(4):257-63. PubMed ID: 12122231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood viscosity and erythrocyte deformability in diabetic retinopathy].
    Melli M; Poggi M; Codeluppi L; Baraldi P; Torlai F; Peduzzi M
    Ric Clin Lab; 1983; 13 Suppl 3():371-4. PubMed ID: 6673016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma-erythrocyte viscosity and evaluation of several pro- and anti-aggregating factors in NIDDM patients in metabolic decompensation state].
    Cortinovis A; Crippa A; Crippa M; Bosoni T; Moratti R
    Minerva Cardioangiol; 1992 Sep; 40(9):317-22. PubMed ID: 1470397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
    Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
    Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Are rheological markers of poor prognosis present in diabetic arteriopathies?].
    Boisseau MR
    J Mal Vasc; 2001 Apr; 26(2):117-21. PubMed ID: 11319417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of hemorheological behaviour for patients with Alzheimer's disease at the early stages.
    Wen Z; Xie J; Guan Z; Sun D; Yao W; Chen K; Yan ZY; Mu Q
    Clin Hemorheol Microcirc; 2000; 22(4):261-6. PubMed ID: 11081463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.